InvestorsHub Logo
Followers 80
Posts 5436
Boards Moderated 0
Alias Born 06/11/2010

Re: None

Friday, 02/22/2013 1:22:31 AM

Friday, February 22, 2013 1:22:31 AM

Post# of 158400
BMSN. BMSN. http://www.sbwire.com/press-releases/bio-matrix-scientific-group-inc-pinkbmsn-goes-to-fda-for-clinical-trials-of-highly-anticipated-drug-210890.htm. BMSN. BMSN. Re: None

Post # of 2924191

Tomorrow ENTB/BMSN Run HARD!! These Sisters have legs!!

Las Vegas, NV -- (SBWIRE) -- 02/21/2013 -- Bio Matrix Scientific Group Inc (PINK:BMSN) has recently applied in FDA to initiate clinical trials on HemaXellarate stem cell drug. The application in FDA is officially filed through the company’s fully owned subsidiary Regen BioPharma. The respective drug is used in treatment of patients with drug refractory aplastic anaemia.

Bio Matrix Scientific Group has also recently published a scientific rational for its HemaXellarate product with the help of globally renowned researchers.

The company’s management is very enthusiastic on its new product as the HemaXellerate is believed to be only therapy which has ability to treat aplastic anemia as well rebuilds the bone marrow tissue at the same time.

The share price is up 9.62 percent in today’s session in the morning at $0.0111. Almost 17.03 shares are traded in first hour of the session as compared to its average daily volume of 121.68 million shares.

To find out what OTCMAGIC projects for Bio Matrix Scientific Group Inc for both short term and long term please click here: BMSN

SBWire (http://s.tt/1A3zN)

BMSN. BMSN.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.